Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype

doi:10.3748/wjg.v20.i21.6400

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 21

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8812)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

657

WORD

264

HTML

5915

Figures (1-6)

212

Tables (1-1)

161

Sum=7209

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

927

Download

676

Sum=1603

Jun 7, 2014 (publication date) through Jul 2, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 7, 2014; 20(21): 6400-6411
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6400

Full Size Figure Download Figure

Figure 2 Metabolism of omeprazole, lansoprazole, rabeprazole, and esomeprazole by cytochrome P450 isoenzymes. Reproduced from Chang et al[61].

Citation: Sugimoto M, Furuta T. Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. World J Gastroenterol 2014; 20(21): 6400-6411
URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6400.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6400